145 related articles for article (PubMed ID: 37819195)
1. Novel perspectives regarding the physiologic mechanisms by which gliflozins induce reticulocytosis and erythrocytosis.
Heyman SN; Armaly Z; Hamo-Giladi DB; Abassi Z
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E621-E623. PubMed ID: 37819195
[TBL] [Abstract][Full Text] [Related]
2. Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
Heyman SN; Abassi Z
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510986
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors.
Packer M
Eur Heart J; 2023 Dec; 44(48):5027-5035. PubMed ID: 37086098
[TBL] [Abstract][Full Text] [Related]
4. Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.
Marathias KP; Lambadiari VA; Markakis KP; Vlahakos VD; Bacharaki D; Raptis AE; Dimitriadis GD; Vlahakos DV
Am J Nephrol; 2020; 51(5):349-356. PubMed ID: 32241009
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M
Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
[TBL] [Abstract][Full Text] [Related]
6. Regulation of erythropoietin production.
Jelkmann W
J Physiol; 2011 Mar; 589(Pt 6):1251-8. PubMed ID: 21078592
[TBL] [Abstract][Full Text] [Related]
7. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia.
Cui Y; Li H; Yu SJ; Afedo SY; Bai XF
J Mol Histol; 2022 Apr; 53(2):395-411. PubMed ID: 35084636
[TBL] [Abstract][Full Text] [Related]
8. Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin.
Farsijani NM; Liu Q; Kobayashi H; Davidoff O; Sha F; Fandrey J; Ikizler TA; O'Connor PM; Haase VH
J Clin Invest; 2016 Apr; 126(4):1425-37. PubMed ID: 26927670
[TBL] [Abstract][Full Text] [Related]
9. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.
Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH
Blood; 2010 Oct; 116(16):3039-48. PubMed ID: 20628150
[TBL] [Abstract][Full Text] [Related]
10. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
11. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.
Kobayashi H; Liu Q; Binns TC; Urrutia AA; Davidoff O; Kapitsinou PP; Pfaff AS; Olauson H; Wernerson A; Fogo AB; Fong GH; Gross KW; Haase VH
J Clin Invest; 2016 May; 126(5):1926-38. PubMed ID: 27088801
[TBL] [Abstract][Full Text] [Related]
12. Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice.
Nakai T; Iwamura Y; Kato K; Hirano I; Matsumoto Y; Tomioka Y; Yamamoto M; Suzuki N
Blood Adv; 2023 Aug; 7(15):3793-3805. PubMed ID: 37146271
[TBL] [Abstract][Full Text] [Related]
13. S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P
Hafizi R; Imeri F; Wenger RH; Huwiler A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502385
[TBL] [Abstract][Full Text] [Related]
14. Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys.
Broeker KAE; Fuchs MAA; Schrankl J; Lehrmann C; Schley G; Todorov VT; Hugo C; Wagner C; Kurtz A
J Physiol; 2022 Feb; 600(3):671-694. PubMed ID: 34863041
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
[TBL] [Abstract][Full Text] [Related]
16. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
[TBL] [Abstract][Full Text] [Related]
17. Tubular Endogenous Erythropoietin Protects Renal Function against Ischemic Reperfusion Injury.
Yasuoka Y; Izumi Y; Fukuyama T; Oshima T; Yamazaki T; Uematsu T; Kobayashi N; Nanami M; Shimada Y; Nagaba Y; Mukoyama M; Sands JM; Takahashi N; Kawahara K; Nonoguchi H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279224
[TBL] [Abstract][Full Text] [Related]
18. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
[TBL] [Abstract][Full Text] [Related]
19. Does Renal Tubular Injury-Induced Local Tissue Hypoxia Involve Post-Transplantation Erythrocytosis?
Unal A; Ata S; Karakurkcu C; Ciraci MZ; Kocyigit I; Sipahioglu MH; B Tokgoz ; Oymak O
Transplant Proc; 2017 Oct; 49(8):1930-1934. PubMed ID: 28923650
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling.
Souma T; Nezu M; Nakano D; Yamazaki S; Hirano I; Sekine H; Dan T; Takeda K; Fong GH; Nishiyama A; Ito S; Miyata T; Yamamoto M; Suzuki N
J Am Soc Nephrol; 2016 Feb; 27(2):428-38. PubMed ID: 26054543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
